NanoMedU
Learn more about Early Pre-clinical Development Level 1: RNA Vaccines. A focused virtual classroom and hands-on training to kick-start RNA-LNP vaccine development
Learn MoreIgnite Empowers Genetic Medicine Advancement
Learn more about Early Pre-clinical Development Level 1: RNA Vaccines. A focused virtual classroom and hands-on training to kick-start RNA-LNP vaccine development
Learn More
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact a Scientific Specialists.
Get in Touch
Particle Size, polydispersity and hematocrit expression were consistent as production of mRNA-LNP was scaled using the NanoAssemblr platform.
Starting concentration, total flow rate and flow rate ratio parameters were varied, and 5 replicates were performed for each data point.
Particle size and encapsulation efficiency were performed in 4 replicates. Protein expression (Epo) experiments performed to show in vivo efficacy of mRNA-LNP.
The heating package empowers users to heat and keep their formulations in syringes at temperature when operating the Ignite.
GenVoy-ILM is an off-the-shelf, research use only reagent that lowers the barriers the genetic medicine development that can be used on the Ignite.
Single Use Cartridges
No priming or cleaning required for an efficient workflow. Ignite cartridges are compatible with a wide range of solvents to make a diverse array of nanomedicine formulations.
Automatic Inline Dilution
Automated in-line dilution allows modelling of the processes that will be required for future GMP production of nanoparticles.
Publication - Abstract
February 16, 2021
Communications Biology
Publication - Abstract
December 16, 2020
pharmaceutics
Publication - Abstract
December 16, 2020
Advanced Therapeutics
Publication - Abstract
November 30, 2020
International Journal of Pharmaceutics
Publication - Abstract
November 19, 2020
Molecular Pharmaceutics